SGS, the world’s leading testing, inspection and certification company, has published a Consumer Compact article detailing the new EN 17860 standard series for e-cargo bikes.

The market for e-cargo bikes is expected to increase across the globe. Their versatility and eco-friendly advantages make them an attractive solution for lighter-load journeys over shorter distances, avoiding the use of fossil fuels.

This article explores the need for an alternative to existing standards, such as DIN 79010:2020 and EN 15194, as well as addressing the particular issues that the EN 17860 series is designed to address. In recent years, the functionality of e-cargo bikes has come under pressure as their weight-carrying ability has been raised, leading to problems such as cracked frames.

Testing must replicate real-life usage and demonstrate stability. However, the article does describe how distinguishing between commercial and private usage can be problematic, leading to potential noncompliance with the new standards.

Compliance with the standards offers businesses the opportunity to avoid costly recalls whilst ensuring safety. This article explores the development and scope of e-cargo bike regulation in Europe and the testing methodologies and solutions available from SGS.

Read the original Consumer Compact article, ‘Enhancing urban safety: EN 17860 standards and the growing e-cargo bike market’.

SGS solutions
SGS offers a comprehensive range of testing and certification solutions to help manufacturers and suppliers of e-cargo bikes conform to market requirements. In addition to the new EN 17860 series, we can also provide support with other national and international standards for adult and children’s bikes, accessories, chemical and recycling standards.

Learn more about SGS Hardlines services.

Subscribe to receive SGS Consumer Compact direct to your inbox.

For more information, please contact: 

Website: www.sgs.com/ee
LinkedIn: SGS Connectivity & Products

About SGS
We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for sustainability, quality and integrity. Our 99,600 employees operate a network of 2,600 offices and laboratories around the world.

SGS, the world’s leading testing, inspection and certification company, has published SafeGuardS 150.24 to keep stakeholders informed about new measures in California to regulate bisphenols in two categories of product:
- Juvenile feeding products – consumer products designed or intended to be filled with liquid, food or beverage intended primarily for consumption from that bottle or cup by children younger than 12 years of age
- Juvenile sucking or teething products – consumer products designed or intended to help a child younger than 12 years of age with sucking or teething to facilitate sleep or relaxation

SB 1266 (Chapter 790) was signed into law on September 27, 2024. This expands the existing ban on bisphenol A (BPA), as found in the Toxin-Free Infants and Toddlers Act (the Act), to cover all bisphenols above the practical quantitation limit (PQL, as defined under 22 California Code of Regulations §69501.1(a)(52)), to be determined by the Department of Toxic Substances Control (DTSC).

SGS experts publish SafeGuardS to keep stakeholders informed about regulatory changes that may impact their business. SafeGuardS 150.24 covers the background to the Toxin-Free Infants and Toddlers Act and includes a table with highlights of the new scope and requirements.

SB 1266 amends the Health and Safety Code (HSC), Section 108940, and will come into effect on January 1, 2026.

SGS Toy & Juvenile Product Services
SGS offers a wide range of services to ensure that products comply with relevant standards for childcare articles and children’s equipment. They provide consulting, training, product development, testing, audit and inspection services to ensure that products comply with strict regulations worldwide, demonstrating the safety and quality of juvenile products being brought to the market. After all, it’s only trusted because it’s tested. Learn more about SGS’s  Juvenile Product Services.

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full California Bans Bisphenols in Certain Juvenile Products SafeGuardS.

Subscribe today and receive SGS SafeGuardS direct to your inbox.

For further information contact:

Dr. HingWo Tsang
Global Information and Innovation Manager
Tel: (+852) 2774 7420

Melanie Tamayo
Senior Technical Manager, SGS NA.
Tel: + 1 312 414 9394

Website: www.sgs.com/hardlines
LinkedIn: SGS Connectivity & Products

About SGS
We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for sustainability, quality and integrity. Our 99,600 employees operate a network of 2,600 offices and laboratories around the world.

SGS, the world’s leading testing, inspection and certification company, is excited to announce that it will once again be at SupplySide West and Food Ingredients North America, ready to help companies protect their products and brands at every stage of the supply chain.

SupplySide West and Food Ingredients North America is the premier gathering for health and nutrition professionals. It brings together experts, buyers and suppliers in the dietary supplement, food and beverage, pet health, personal care and sports nutrition sectors to explore the science and strategies for successful market access.

SGS’s multidisciplinary team will be available at booth #5036 throughout the two-day expo, ready to answer questions concerning:
- Testing and analysis
- Clinical trials
- Audit and certification
- Regulatory compliance and advisory services
- Social and sustainability
- Training
- Tailored solutions

In addition, representatives from SGS Nutrasource will be available to discuss its expanded range of specialized services for clinical trial management, regulatory support, testing and product research and development. They will also provide information about their series of third-party natural ingredient certification programs:
- NutraStrong™
- International Fish Oil Standards (IFOS™)
- International Krill Oil Standards (IKOS™)
- International Algal Oil Standards (IAOS™)
- International Genetically Modified Organism (GMO) Evaluation and Notification Program (IGEN™)
- International Probiotics Testing Standards (IPRO™)
- Radioactivity Tested & Certified

During the event, Stephanie-Anne Girard, PhD, Director of Scientific Affairs at SGS Nutrasource, will participate in two speaking engagements: ‘Ingredient claims and legal flames: An interactive workshop to dodge regulatory heat’ (October 28 – 2-4 pm PST) and ‘Women's health: The trends, clinical studies and ingredients helping women thrive’ (October 29 – 9-11 am PST). Each event will provide in-depth insights into these rapidly evolving topics to help businesses stay at the forefront of regulatory and consumer trends.

SupplySide West and Food Ingredients North America 2024 takes place in Las Vegas, Nevada, from October 28-31, 2024. It attracts over 1,500 companies and more than 20,000 attendees, making it the premier gathering for professionals in the health and nutrition community.

Delegates can find the SGS team at booth #5036 or book a meeting by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.

For further information contact:

Jennifer Buckley
Senior Global Marketing Manager, SGS
Health & Nutrition
Tel: 973 461 1498

About SGS 
We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for sustainability, quality and integrity. Our 99,600 employees operate a network of 2,600 offices and laboratories around the world.

SGS, the world’s leading testing, inspection and certification company, has set a new benchmark for third-party pharmaceutical testing laboratories in China following an outstanding inspection by the US Food and Drug Administration (FDA) of its Shanghai Health Science Laboratory.

For a third consecutive time, the facility was not issued a Form FDA 483 at the conclusion of the US FDA’s comprehensive inspection (Zero 483 inspectional observations), becoming the first third-party pharmaceutical testing laboratory in China to achieve this accolade.

In the global pharmaceutical market, international recognition of pharmaceutical quality systems is critical for companies to gain market access. As a globally recognized regulatory authority, the US FDA protects public health by ensuring the safety, efficacy and security of human and veterinary drugs, biological products and medical devices. To this end, GMP on-site inspections evaluate whether a company's operations quality management system meets international standards.

Over four days in September 2024, US FDA inspectors undertook a full-scope GMP compliance inspection of SGS’s Shanghai facility. Its focus included quality management, chemical and microbiological quality control laboratory management, sample management, personnel training, hardware/software system validation, method validation, documentation and records, electronic data management and data integrity.

Additionally, inspectors conducted on-site reviews of actual tests in physical, chemical, microbiological and sterile testing laboratories. 

Dr. Sandy Hao, Managing Director of SGS in China, said: “Our Shanghai Health Science Laboratory’s successful completion of the US FDA GMP on-site inspection with a zero 483 observations result is not only a testament to our long-standing commitment to excellent laboratory management practices but also a further consolidation of our authority and professionalism in the third-party pharmaceutical testing field.

“Our team continuously embraces SGS’s ‘Quality First’ mission to further enhance pharmaceutical brand reputation and customer confidence. With SGS support, Chinese pharmaceutical product manufacturers will continue to improve market reputation and customer trust, and readily access global markets. In partnership with our global pharmaceutical customers, we aim to drive the long-term, high-quality development of the healthcare industry in China.”

SGS provides analytical services spanning the entire drug development life cycle, including GMP-compliance QC testing, bioanalysis and clinical research, formulation development. We cover all segments such as chemical drugs, biopharmaceuticals, medical devices and pharmaceutical packaging materials.

SGS is committed to providing higher quality services to pharmaceutical companies in China and globally, helping products to be marketed efficiently and safely, and offering a solid guarantee for the health of patients worldwide.

About SGS 
We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for sustainability, quality and integrity. Our 99,600 employees operate a network of 2,600 offices and laboratories around the world.